Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal
Disease Category: Osteoarthritis
Trial Information
A Phase 3, Multi-Center, Randomized, Double-Blind, Controlled Study of the Long-Term Analgesic Efficacy and Safety of Tanezumab Alone or in Combination with Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) Versus NSAIDS Alone in Patients with Osteoarthritis of the Knee or Hip
The purpose of the study is to determine whether the study drug, tanezumab, when used alone or together with an NSAID, is more effective than the NSAID alone when used by subjects with pain due to osteoarthritis of the knee or hip.
Patient Inclusion Criteria:
- Must be 18 years or older
- Must have been diagnosed with OA of the knee or hip
- Currently taking naproxen or celecoxib and receiving some relief
Patient Exclusion Criteria: History of significant trauma or surgery to the index knee or hip within the previous year.
Dr. David Burack
Carolinas Research Associates
744 Arden Lane
Rock Hill, SC 29732
Phone: 704-366-3001
EMail: contact@carolinasresearch.com
View Google Map
Research Center Information: Carolinas Research Associates
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
